Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 18;26(10):e132-e133.
doi: 10.1093/ibd/izaa170.

The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis

Muhammad Aziz  1 , Rawish Fatima  1 , Hossein Haghbin  1 , Wade Lee-Smith  2 , Ali Nawras  3
Affiliations
Comment

The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis

Muhammad Aziz et al. Inflamm Bowel Dis. .
No abstract available

Keywords: COVID-19; Crohn’s disease; SARS-CoV-2; inflammatory bowel disease; ulcerative colitis.

PubMed Disclaimer

Comment in

Comment on

References

    1. Burgueño JF, Reich A, Hazime H, et al. . Expression of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBD. Inflamm Bowel Dis. 2020;26:797–808. - PMC - PubMed
    1. Allocca M, Fiorino G, Zallot C, et al. . Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts. Clin Gastroenterol Hepatol. 2020; doi: 10.1016/j.cgh.2020.04.071. - DOI - PMC - PubMed
    1. Bezzio C, Saibeni S, Variola A, et al. ; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69:1213–1217. - PubMed
    1. Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020; doi: 10.1002/jmv.25948. - DOI - PMC - PubMed

Substances